Armata Pharmaceuticals (ARMP) Operating Income Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.08% |
| Dec 31, 2025 | -16.46% |
| Sep 30, 2025 | -6.70% |
| Jun 30, 2025 | -8.32% |
| Mar 31, 2025 | -10.73% |
| Dec 31, 2024 | -19.22% |
| Sep 30, 2024 | -7.56% |
| Jun 30, 2024 | -18.23% |
| Mar 31, 2024 | -24.34% |
| Dec 31, 2023 | -27.94% |
| Sep 30, 2023 | -33.59% |
| Jun 30, 2023 | -27.63% |
| Mar 31, 2023 | -30.01% |
| Dec 31, 2022 | -34.29% |
| Sep 30, 2022 | -63.15% |
| Jun 30, 2022 | 0.98% |
| Mar 31, 2022 | -21.17% |
| Dec 31, 2021 | 12.61% |
| Sep 30, 2021 | -12.51% |
| Jun 30, 2021 | -11.54% |
| Mar 31, 2021 | -3.76% |
| Dec 31, 2020 | -17.03% |
| Sep 30, 2020 | -18.29% |
| Jun 30, 2020 | -12.11% |
| Mar 31, 2020 | -16.77% |
| Dec 31, 2019 | -11.00% |
| Sep 30, 2019 | -5.32% |
| Jun 30, 2019 | -6.59% |
| Mar 31, 2019 | -6.31% |
| Dec 31, 2018 | -1.56% |
| Sep 30, 2018 | -0.74% |
| Jun 30, 2018 | 14.23% |
| Mar 31, 2018 | -18.04% |